Jeremy Bender, CHIEF EXECUTIVE OFFICER at Day One Biopharmaceuticals, Inc. (DAWN), sold 30,918 shares at $11.60 ($359K) on 2026-02-17, disclosed to the SEC on 2026-02-18.
Seasonal sale ($359k) by CHIEF EXECUTIVE OFFICER — this insider has traded DAWN in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.60 | 15,459 | $179K | 50.0% |
| 2 | $11.60 | 15,459 | $179K | 50.0% |
| Total | $11.60 avg | 30,918 | $359K | 100% |
| Filing → |
| DAWN | SELL | 2025-05-19 | $175K | — | Filing → |
| DAWN | SELL | 2025-02-21 | $288K | — | Filing → |
| DAWN | SELL | 2024-11-19 | $279K | — | Filing → |